1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Voltage-Dependent T-Type Calcium Channel Blockers -Pipeline Insights, 2016


DelveInsight’s, “Voltage-Dependent T-Type Calcium Channel Blockers-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Voltage-Dependent T-Type Calcium Channel Blockers. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Voltage-Dependent T-Type Calcium Channel Blockers. DelveInsight’s Report also assesses the Voltage-Dependent T-Type Calcium Channel Blockers therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope
- The report provides competitive pipeline landscape of Voltage-Dependent T-Type Calcium Channel Blockers
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Voltage-Dependent T-Type Calcium Channel Blockers pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Voltage-Dependent T-Type Calcium Channel Blockers and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Table Of Contents

Voltage-Dependent T-Type Calcium Channel Blockers -Pipeline Insights, 2016

- Voltage-Dependent T-Type Calcium Channel Blockers Overview
- Voltage-Dependent T-Type Calcium Channel Blockers Disease Associated
- Voltage-Dependent T-Type Calcium Channel Blockers Pipeline Therapeutics
- Voltage-Dependent T-Type Calcium Channel Blockers Therapeutics under Development by Companies
- Voltage-Dependent T-Type Calcium Channel Blockers Filed and Phase III Products
- Comparative Analysis
- Voltage-Dependent T-Type Calcium Channel Blockers Phase II Products
- Comparative Analysis
- Voltage-Dependent T-Type Calcium Channel Blockers Phase I and IND Filed Products
- Comparative Analysis
- Voltage-Dependent T-Type Calcium Channel Blockers Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Voltage-Dependent T-Type Calcium Channel Blockers - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Voltage-Dependent T-Type Calcium Channel Blockers - Discontinued Products
- Voltage-Dependent T-Type Calcium Channel Blockers - Dormant Products
- Companies Involved in Therapeutics Development for Voltage-Dependent T-Type Calcium Channel Blockers
- Appendix
- Methodology
- Contact Us
- Disclaimer


List of Tables

- Number of Products under Development for Voltage-Dependent T-Type Calcium Channel Blockers by Therapy Area, 2016
- Number of Products under Development for Voltage-Dependent T-Type Calcium Channel Blockers, 2016
- Number of Products under Development by Companies
- Comparative Analysis by Filed and Phase III Products, 2016
- Comparative Analysis Phase II Products, 2016
- Comparative Analysis Phase I and IND Filed Products, 2016
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2016
- Drug Candidates Profiles
- Voltage-Dependent T-Type Calcium Channel Blockers Assessment by Monotherapy Products
- Voltage-Dependent T-Type Calcium Channel Blockers Assessment by Combination Products
- Voltage-Dependent T-Type Calcium Channel Blockers Assessment by Route of Administration
- Voltage-Dependent T-Type Calcium Channel Blockers Assessment by Stage and Route of Administration
- Voltage-Dependent T-Type Calcium Channel Blockers Assessment by Molecule Type
- Voltage-Dependent T-Type Calcium Channel Blockers Assessment by Stage and Molecule Type
- Voltage-Dependent T-Type Calcium Channel Blockers Therapeutics - Discontinued Products
- Voltage-Dependent T-Type Calcium Channel Blockers Therapeutics - Dormant Products
- Products under Development by Companies, 2016

List of Figures

- Number of Products under Development for Voltage-Dependent T-Type Calcium Channel Blockers by Therapy Area, 2016
- Number of Products under Development for Voltage-Dependent T-Type Calcium Channel Blockers, 2016
- Filed and Phase III Products, 2016
- Phase II Products, 2016
- Phase I and IND Filed Products, 2016
- Discovery and Pre-Clinical Stage Products, 2016
- Voltage-Dependent T-Type Calcium Channel Blockers Assessment by Monotherapy Products
- Voltage-Dependent T-Type Calcium Channel Blockers Assessment by Combination Products
- Voltage-Dependent T-Type Calcium Channel Blockers Assessment by Route of Administration
- Voltage-Dependent T-Type Calcium Channel Blockers Assessment by Stage and Route of Administration
- Voltage-Dependent T-Type Calcium Channel Blockers Assessment by Molecule Type
- Voltage-Dependent T-Type Calcium Channel Blockers Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Verapamil (Calan, Verelan)-A Calcium Channel Blocker for the treatment of Heart Attack:Patent Overview (Last 5 years)

Verapamil (Calan, Verelan)-A Calcium Channel Blocker for the treatment of Heart Attack:Patent Overview (Last 5 years)

  • $ 2000
  • Industry report
  • November 2016
  • by Mordor Intelligence LLP

The embodiment of one of the patents published in 2011 teaches on “In a further aspect there is provided a method of treating a cardiovascular condition, the method comprising administering a press-coated ...

Nisoldipine (Sular)-A Calcium Channel Blocker for the treatment of Heart Attack:Patent Overview (Last 5 years)

Nisoldipine (Sular)-A Calcium Channel Blocker for the treatment of Heart Attack:Patent Overview (Last 5 years)

  • $ 2000
  • Industry report
  • November 2016
  • by Mordor Intelligence LLP

"Controlled release formulations of nisoldipine" is titled for one of the patents that was applied by one of the assignees Emcure Pharmaceuticals Limited.This patent is published in the year 2013.There ...

Voltage-Dependent Calcium Channel Blockers -Pipeline Insights, 2016

Voltage-Dependent Calcium Channel Blockers -Pipeline Insights, 2016

  • $ 1250
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s, “Voltage-Dependent Calcium Channel Blockers-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Voltage-Dependent ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market and Hypertension Statistics in Asia and the US

  • November 2016
    26 pages
  • Therapy  

    Hypertension  

    Cardiovascular ...  

  • Asia  

    United States  

    Europe  

View report >

Anti-Infective and Therapy Market in the US

  • November 2016
    249 pages
  • Anti-Infective  

    Therapy  

    Hormone  

  • United States  

View report >

Anti-Infective and Therapy Market in the US - Forecast

  • November 2016
    249 pages
  • Anti-Infective  

    Therapy  

    Hormone  

  • United States  

View report >

Related Market Segments :

Calcium Channel Blocker

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.